Several studies have implicated the loss of RelB in DCs as a key driver of autoimmunity in RelB−/− mice, demonstrating the sufficiency of either the absence or presence of RelB in DCs alone in promoting or suppressing the inflammatory pathology, respectively, in the lung, liver, spleen and thymus21–23. This evidence concerns the gene RELB and Autoimmunity.